BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samanta D. A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development. Epilepsy Behav 2022;128:108577. [PMID: 35151190 DOI: 10.1016/j.yebeh.2022.108577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Reddy DS. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies. Exp Neurol 2023;359:114237. [PMID: 36206806 DOI: 10.1016/j.expneurol.2022.114237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Elkommos S, Mula M. Current and future pharmacotherapy options for drug-resistant epilepsy. Expert Opin Pharmacother 2022. [PMID: 36154780 DOI: 10.1080/14656566.2022.2128670] [Reference Citation Analysis]
3 Samanta D. Pharmacotherapeutic management of seizures in patients with Angleman syndrome. Expert Opin Pharmacother 2022. [PMID: 35862628 DOI: 10.1080/14656566.2022.2105141] [Reference Citation Analysis]